These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19525294)

  • 1. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy.
    Duboscq-Bidot L; Charron P; Ruppert V; Fauchier L; Richter A; Tavazzi L; Arbustini E; Wichter T; Maisch B; Komajda M; Isnard R; Villard E;
    Eur Heart J; 2009 Sep; 30(17):2128-36. PubMed ID: 19525294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy.
    Arimura T; Bos JM; Sato A; Kubo T; Okamoto H; Nishi H; Harada H; Koga Y; Moulik M; Doi YL; Towbin JA; Ackerman MJ; Kimura A
    J Am Coll Cardiol; 2009 Jul; 54(4):334-42. PubMed ID: 19608031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy.
    Duboscq-Bidot L; Xu P; Charron P; Neyroud N; Dilanian G; Millaire A; Bors V; Komajda M; Villard E
    Cardiovasc Res; 2008 Jan; 77(1):118-25. PubMed ID: 18006477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return.
    Cinquetti R; Badi I; Campione M; Bortoletto E; Chiesa G; Parolini C; Camesasca C; Russo A; Taramelli R; Acquati F
    Hum Mutat; 2008 Apr; 29(4):468-74. PubMed ID: 18273862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha B-crystallin mutation in dilated cardiomyopathy.
    Inagaki N; Hayashi T; Arimura T; Koga Y; Takahashi M; Shibata H; Teraoka K; Chikamori T; Yamashina A; Kimura A
    Biochem Biophys Res Commun; 2006 Apr; 342(2):379-86. PubMed ID: 16483541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
    Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene.
    Moulik M; Vatta M; Witt SH; Arola AM; Murphy RT; McKenna WJ; Boriek AM; Oka K; Labeit S; Bowles NE; Arimura T; Kimura A; Towbin JA
    J Am Coll Cardiol; 2009 Jul; 54(4):325-33. PubMed ID: 19608030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy.
    Meyer T; Ruppert V; Ackermann S; Richter A; Perrot A; Sperling SR; Posch MG; Maisch B; Pankuweit S;
    Eur J Hum Genet; 2013 Mar; 21(3):294-300. PubMed ID: 22892539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of desmin mutations in dilated cardiomyopathy.
    Taylor MR; Slavov D; Ku L; Di Lenarda A; Sinagra G; Carniel E; Haubold K; Boucek MM; Ferguson D; Graw SL; Zhu X; Cavanaugh J; Sucharov CC; Long CS; Bristow MR; Lavori P; Mestroni L; ;
    Circulation; 2007 Mar; 115(10):1244-51. PubMed ID: 17325244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intron retention generates ANKRD1 splice variants that are co-regulated with the main transcript in normal and failing myocardium.
    Torrado M; Iglesias R; Nespereira B; Centeno A; López E; Mikhailov AT
    Gene; 2009 Jul; 440(1-2):28-41. PubMed ID: 19341785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy.
    Arimura T; Hayashi T; Matsumoto Y; Shibata H; Hiroi S; Nakamura T; Inagaki N; Hinohara K; Takahashi M; Manatsu SI; Sasaoka T; Izumi T; Bonne G; Schwartz K; Kimura A
    Biochem Biophys Res Commun; 2007 May; 357(1):162-7. PubMed ID: 17416352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome.
    Ruppert V; Nolte D; Aschenbrenner T; Pankuweit S; Funck R; Maisch B
    Biochem Biophys Res Commun; 2004 May; 318(2):535-43. PubMed ID: 15120634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.
    Crocini C; Arimura T; Reischmann S; Eder A; Braren I; Hansen A; Eschenhagen T; Kimura A; Carrier L
    Basic Res Cardiol; 2013 May; 108(3):349. PubMed ID: 23572067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.
    Taylor MR; Slavov D; Gajewski A; Vlcek S; Ku L; Fain PR; Carniel E; Di Lenarda A; Sinagra G; Boucek MM; Cavanaugh J; Graw SL; Ruegg P; Feiger J; Zhu X; Ferguson DA; Bristow MR; Gotzmann J; Foisner R; Mestroni L;
    Hum Mutat; 2005 Dec; 26(6):566-74. PubMed ID: 16247757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a missense mutation in the melusin-encoding ITGB1BP2 gene in a patient with dilated cardiomyopathy.
    Ruppert V; Meyer T; Richter A; Maisch B; Pankuweit S;
    Gene; 2013 Jan; 512(2):206-10. PubMed ID: 23124043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enigmatic role of the ankyrin repeat domain 1 gene in heart development and disease.
    Mikhailov AT; Torrado M
    Int J Dev Biol; 2008; 52(7):811-21. PubMed ID: 18956313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titin mutations as the molecular basis for dilated cardiomyopathy.
    Itoh-Satoh M; Hayashi T; Nishi H; Koga Y; Arimura T; Koyanagi T; Takahashi M; Hohda S; Ueda K; Nouchi T; Hiroe M; Marumo F; Imaizumi T; Yasunami M; Kimura A
    Biochem Biophys Res Commun; 2002 Feb; 291(2):385-93. PubMed ID: 11846417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.
    Scurr LL; Guminski AD; Chiew YE; Balleine RL; Sharma R; Lei Y; Pryor K; Wain GV; Brand A; Byth K; Kennedy C; Rizos H; Harnett PR; deFazio A
    Clin Cancer Res; 2008 Nov; 14(21):6924-32. PubMed ID: 18980987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy.
    Olson TM; Kishimoto NY; Whitby FG; Michels VV
    J Mol Cell Cardiol; 2001 Apr; 33(4):723-32. PubMed ID: 11273725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.